Stacie and others: a review of the treatment options

Dear Geoff-

Glad to hear your good news about your scan!

It is stressful waiting to get results. I don’t seem to be landing in the good percentages with all of this, but maybe I’ll have better luck tomorrow. I have also heard 35% is the success rate, but I’ve heard some news that it is improving.

I am bracing myself for bad news. I always go to the mall and buy shoes if that ‘s the case. Most of the time I buy Crocs. I have six pair now in assorted colors. I still want yellow, red, and lime green.

I don’t know why, but I got the same impression about the Davanat trial as you did – that after a while, they may take people who have been on chemo. They may not get that many CC patients unless they lift the restriction.

We may get home very late tomorrow, but I’ll try to post my results as soon as possible.

-Caroline

Geoff-

I am having some luck with Xeloda!

Initially, I went off of it because of hand-foot syndrome and my feet swelling. But on my last two blood tests, my liver enzymes have improved, so I went back on it. My oncologist feels it’s the Xeloda that made the difference. I try not to work long days on my feet and that has helped the hand-foot syndrome.

I have a scan this week very early on Wednesday morning and then chemo (Gemzar) in the afternoon. (I am taking the Xeloda orally.) I don’t know if or when we’ll add the Avastin. This week’s scan will probably help determine that. While the results of the scan won’t be back on Wednesday afternoon, Dr. Bergen said he’s going to run upstairs to the imaging center and find a radiologist who will at least give him a preliminary report on my scan.

I’m not expecting good news. Everytime I get a scan, my tumors have grown back, or doubled, or more have grown. But hopefully, they will have slowed down a bit. This is my first scan since chemo. My last scan was about three months ago when I was on the trial for Sorafenib.

As for Davanat, the people who have contacted me and made some posts on this site are shareholders in the company and not the company itself. I am keeping the possibility of compassionate use of Davanat on the back burner. The Phase II clinical trial probably just opened, but they’re looking for people who have never been on chemo. Had I not been on chemo, I would consider this trial. But after I went off the Sorafenib trial, I just felt like I couldn’t wait three months to have a new treatment.

The two shareholders of Pro-Pharmaceutical (makers of Davanat) who contacted me had family members who had cancer. Tom’s mother had colon cancer and he tried to get her into the Phase I Davant trial, but she died before they could get her in. He also had an aunt that died of CC several years ago. I think his motives were genuine – he just wanted to let people know about the drug that he felt might have saved his mother. He bought stock in the company as a result of the research he had done to help his mother. My doctor and I had both called Pro-Pharmaceuticals about the trial, but the doctor in charge of the trial said I wasn’t eligible. Tom called the doctor on my behalf as well, but was informed of the same thing – since I was on chemo, I wasn’t eligible. The clinical trial doctor said he felt it was better to stick with Gemzar and other traditional treatments with a proven track record rather than an experimental drug. He also mentioned that at the big oncology conference this summer in the US it was reported that Gemzar is showing better results than previously thought.

Hope this helps,
Caroline

Geoff,

Here are my suggestions: I’ll try to go right down your list. There are others who know more than me out there, so (others) please feel free to correct or add to what is here.

Avastin: I think if you are doing chemo it is a must – it has boosted good results with every kind of cancer it has been tried on. Check pub med and you will find several studies/articles/peer-reviewed materials there that can help you. Also, you can go to the “Getting Avastin” area on the website – there is a post there through me from a good Dr. friend and he gives several good suggestions on getting Avastin into your regimen.

Davanat: You can’t get it. Hopefully Caroline will keep us updated on the progress with her compassionate use request, but other than that it really isn’t available and there aren’t any peer-reviewed articles to read on it.

Sorafenib: I think we were all hopeful that this one would do a better job with cholangio, I haven’t heard any good results from this trial – perhaps Hans knows more as he was also on the trial (which did not work for him either).

XL119 – I have not studied this drug and so I can not speak to its efficacy but pubmed should be able to help you out there as well.

Immunotherapy is just coming so we will all be watching this one.

As far as alternative therapies, I will know much more about this and the direction we will be going with Mark next week. We have our appointment to lay everything out and we are very interested to see how this will go. I should tell you that one of the reports that I read said that AHCC and Avemar together were having excellent results so this is something we will be going after as well.

Mark’s scan was yesterday and so we are patiently waiting to hear the results. If what they say is true and the amount of rash determines how well the Erbitux is working then he should be cancer free (haha). We’ll let you know.

5FU and Xeloda are the same thing. Just in different forms. Mark is on 5FU, Avastin and Erbitux right now, he is tolerating them far better than the GemOx (Gemcitabine & Oxaliplatin with Avastin) that he was doing before – so we will see.

Hope this is helpful, but I hope others will post as well. It is always best to have many opinions.

Good Luck, keep us updated!
Stacie